CHICAGO--(BUSINESS WIRE)--MAIA Biotechnology Announces Peer-Reviewed Journal Publication of Data Validating Second Generation Ateganosine Prodrugs for Anticancer Therapy... .
MAIA Biotechnology Announces Peer-Reviewed Journal Publication of Data Validating Second Generation Ateganosine Prodrugs for Anticancer Therapy... The manuscript with the data was published on June 26, 2025, in Volume 53, Issue 12 of the NAR journal.
This "Medicare Part C and Part D Data Validation (42 CFR 422.516(g) and 423.514(j))" forms will be used by Data Validation Contractors (DVCs) to evaluate the quality of data submitted by ...
According to the article, all-payor claims data from more than 11.4 million adult ... Using rigorous data extraction, matching and statistical analysis methodology, the study conducted by Strom et al.